Chronic Myeloproliferative Disorders Active Not Recruiting Phase 1 / 2 Trials for Methotrexate (DB00563)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00448357Fludarabine and PK-Directed Busulfan With or Without ATG Followed By Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseasesTreatment